Patent · US Active

Alpha-4-beta-7 heterodimer specific antagonist antibody

US8871490B2 · kind B2 · utility

2Cited by
3References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 22, 2013
Grant dateOct 28, 2014
Priority date—
Expiry dateApr 26, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There are disclosed alpha4beta7 heterodimer-specific antigen binding proteins, nucleic acids encoding them, and methods of making and using them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.